Optimizing Development Programs for Regulatory Approvals:
The Importance of Phase II
Re-Thinking why Trials Fail and how to Balance an Optimal Trial Design with FDA Prospective
Dr. Olga Kubassova
IAG's CEO - Webinar Host
Dr. Lee Simon
IAG's Member of Scientific Advisory Board - Webinar Presenter